MENU
SABS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
SAB Biotherapeutics (SABS) Ownership - Who owns SAB Biotherapeutics?
Profile
Industry
N/A
Address
2100 East 54th Street North
Phone
+1 605 679-6980
Employees
57
Web
https://www.sabbiotherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.19M
P/E Ratio
N/A
Total Cash
30.4M
Projected Growth
N/A
Total Debt
4.52M
Revenue
N/A
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash/Share
3.29
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SABS
Capitalization
37.2M
P/E Ratio
N/A
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash
30.4M
Total Cash/Share
3.29
Total Debt
4.52M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
36.9M
P/B Ratio
1.01
Cash Flow
N/A
Earnings
-6.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
929
Current Ratio
3.69
Current Revenue Per Employee
10376.80
Dividends Per Share - Security
N/A
EBITDA
-40.29M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-110.96
Shares Held By Institutions
10.3M
Shares Outstanding - Current
9.23M
Total Liabilities
16.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-41.382
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2100 East 54th Street North
Phone
+1 605 679-6980
Employees
57
Web
https://www.sabbiotherapeutics.com